Stock A001060 JW PHARMACEUTICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Calendar JW Pharmaceutical Corporation

Equities

A001060

KR7001060003

End-of-day quote Korea S.E.
Other stock markets
 06/09/2024 		5-day change 1st Jan Change
27,000.00 KRW -2.88% Intraday chart for JW Pharmaceutical Corporation -8.94% -24.05%
14/08 JW Pharmaceutical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
10/06 Kissei Pharmaceutical Licenses Linzagolix to JW Pharmaceutical for Korean Market MT

Chart calendar JW Pharmaceutical Corporation

6d0fdf38c0bdac0e.r5ulW0lwaUj-9r4NYT1Q0Bacs4KC44xHQsbeBvWb660.xKKQOnsGGzqvgM1gFFYysiKr0u3riuAPc4-daJ7Tu9fZ7N8pJEkuOYeS3Q~3a325678ceaa564d2bdde1b2533f30b7

Upcoming events on JW Pharmaceutical Corporation

13/11/2024 Q3 2024 Earnings Release (Projected)
07/04/2025 Q4 2024 Earnings Release (Projected)
19/05/2025 Q1 2025 Earnings Release (Projected)
13/08/2025 Q2 2025 Earnings Release (Projected)

Past events on JW Pharmaceutical Corporation

14/08/2024 Q2 2024 Earnings Release
14/05/2024 Q1 2024 Earnings Release
27/03/2024 Annual General Meeting
18/03/2024 Q4 2023 Earnings Release
15/05/2023 Q1 2023 Earnings Release
21/03/2023 Q4 2022 Earnings Release
14/11/2022 Q3 2022 Earnings Release
16/08/2022 Interim 2022 Earnings Release
16/05/2022 Q1 2022 Earnings Release
17/08/2021 Interim 2021 Earnings Release
17/05/2021 Q1 2021 Earnings Release
18/03/2021 FY 2020 Earnings Release
30/03/2020 FY 2019 Earnings Release
14/11/2019 Q3 2019 Earnings Release
15/05/2019 Q1 2019 Earnings Release
14/08/2018 Interim 2018 Earnings Release
03/06/2016 Sachs Associates Immuno-Oncology BD&L and Investment Forum

Past dividends on JW Pharmaceutical Corporation

27/12/2023 Annual 400 KRW
28/12/2022 Annual 375 KRW
29/12/2021 Annual 325 KRW
29/12/2020 Annual 325 KRW
27/12/2019 Annual 325 KRW
27/12/2018 Annual 325 KRW
27/12/2017 Annual 275 KRW
28/12/2016 Annual 142.857 KRW
29/12/2015 119.0475 KRW
29/12/2014 Annual 125 KRW
27/12/2013 Annual 125 KRW
27/12/2012 Annual 125 KRW
28/12/2011 Annual 200 KRW
29/12/2010 Annual 300 KRW
29/12/2009 Annual 300 KRW
29/12/2008 Annual 300 KRW
27/12/2007 Annual 600 KRW
27/12/2006 Annual 500 KRW
28/12/2005 Annual 500 KRW
29/12/2004 Annual 700 KRW

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025 2026
Net sales
Billions KRW		Released
Forecast
Spread 		0,00


684
672
1.84%		750
750
-0.01%
803


872


947

EBITDA
Billions KRW		Released
Forecast
Spread 		0,00


79,8
69,0
15.65%		123
115
6.94%
134


145


157

EBIT
Billions KRW		Released
Forecast
Spread 		0,00


64,4
55,0
17.17%		99,6
95,5
4.23%
108


119


130

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		0,00


46,4
45,0
3.14%		51,6
56,0
-7.84%
103


114


126

Net income
Billions KRW		Released
Forecast
Spread 		-0,92


33,5
34,0
-1.32%		34,8
44,5
-21.7%
78,3


89,6


99,1

EPS
KRW		Released
Forecast
Spread 		-40,0


1 305
1 512
-13.72%		1 529
1 851
-17.4%
3 331


3 814


4 226

Announcement Date21/03/2208/02/2305/02/24-

Quarterly results

Fiscal PeriodJune 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Billions KRW		Released
Forecast
Spread 		170


193
187
3.4%		173
181
-4.31%		186
185
0.37%		184
193
-4.76%		205
209
-1.67%		181
186
-3.14%		172
192
-10.18%
205


226


197

EBITDA
Billions KRW		Released
Forecast
Spread




















16,4
27,1
-39.56%
34,2


38,0


32,3

EBIT
Billions KRW		Released
Forecast
Spread 		11,6


30,2
17,5
72.36%		20,3
11,8
72.24%		20,6
18,7
10.22%		26,1
19,6
32.97%		33,3
27,4
21.67%		26,2
24,0
9.59%		11,6
21,3
-45.35%
27,6


33,1




Net income
Billions KRW		Released
Forecast
Spread








13,1
13,4
-2.42%		-17,9
14,5
-223.52%		25,0
29,4
-15.09%		20,1
19,5
3.01%		8,51
17,2
-50.52%
19,9


21,2


20,0

Announcement Date15/11/2208/02/2315/05/2314/08/2314/11/2305/02/2414/05/2414/08/24---

Upcoming sector events for JW Pharmaceutical Corporation

09/09/2024 PHARMANUTRA S.P.A.: Q2 2024 Earnings Release
03/10/2024 TILRAY BRANDS, INC.: Q1 2025 Earnings Release (Projected)
10/10/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q2 2025 Earnings Release
10/10/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q2 2024 Earnings Release
10/10/2024 10:30 am FAGRON N.V.: Q3 2024 Sales and Revenue Release - Trading Update
15/10/2024 04:15 pm JOHNSON & JOHNSON: Q3 2024 Earnings Release
16/10/2024 SSY GROUP LIMITED: Q3 2024 Earnings Release (Projected)
16/10/2024 GUOBANG PHARMA LTD.: Q3 2024 Earnings Release (Projected)
18/10/2024 GLENMARK LIFE SCIENCES LIMITED: Q2 2025 Earnings Release (Projected)
18/10/2024 SHANDONG WIT DYNE HEALTH CO.,LTD.: Q3 2024 Earnings Release (Projected)
More events

Past sector events for JW Pharmaceutical Corporation

31/08/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q2 2024 Earnings Release
31/08/2024 HUAPONT LIFE SCIENCES CO.,LTD.: Q2 2024 Earnings Release
31/08/2024 WEDGE INDUSTRIAL CO.,LTD.: Q2 2024 Earnings Release
31/08/2024 JILIN AODONG PHARMACEUTICAL GROUP CO., LTD.: Q2 2024 Earnings Release
31/08/2024 ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.: Q2 2024 Earnings Release
31/08/2024 BEIJING TONGRENTANG CO., LTD: Q2 2024 Earnings Release
31/08/2024 GUANGXI WUZHOU ZHONGHENG GROUP CO.,LTD: Q2 2024 Earnings Release
31/08/2024 JINYU BIO-TECHNOLOGY CO., LTD.: Q2 2024 Earnings Release
31/08/2024 LIAONING CHENG DA CO., LTD.: Q2 2024 Earnings Release
30/08/2024 HUBEI HONGYUAN PHARMACEUTICAL TECHNOLOGY CO., LTD.: Q2 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A001060 Stock
  4. Calendar JW Pharmaceutical Corporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition